Medical Condition News

RSS

New approach to functional bone imaging provides insights into degenerative joint disease

A new approach to functional bone imaging has established that bone metabolism is abnormally elevated in patients with knee osteoarthritis.

13 Jul 2020

Patients with high blood sugar at higher risk of COVID-19 complications

The COVID-19 causes severe disease in patients with underlying health conditions, such as diabetes, hypertension, severe lung disease, heart disease, and a weakened immune system.

13 Jul 2020

Molecular imaging reveals inter-organ communication between the heart and kidneys after heart attack

Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction, or heart attack.

13 Jul 2020

Total-body dynamic PET can generate high-quality images of metastatic cancer

Results from the first study using uEXPLORER to conduct total-body dynamic positron emission tomography (PET) scans in cancer patients show that it can be used to generate high-quality images of metastatic cancer.

13 Jul 2020

New PET/MRI approach can precisely identify location of chronic pain generators

A new molecular imaging approach utilizing 18F-FDG positron emission tomography (PET) and magnetic resonance imaging (MRI) can precisely identify the location of pain generators in chronic pain sufferers, often precipitating a new management plan for patients.

13 Jul 2020

Serology distinguishes children with MIS-C associated with COVID-19

Researchers in the United States say that measuring antibody titers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may help to distinguish between multisystem inflammatory syndrome in children (MIS-C) and other clinically similar syndromes.

13 Jul 2020

Skin rash may be a symptom of COVID-19

Researchers at King’s College London and Zoe Global Ltd have conducted a study suggesting that skin rashes could be valuable predictors of coronavirus disease 2019 (COVID-19).

13 Jul 2020

Study shows safety and effectiveness of PET radiotracer in imaging glioblastomas

A first-in-human study presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting has demonstrated the safety, favorable pharmacokinetic and dosimetry profile of 64Cu-EBRGD, a new, relatively long-lived PET tracer, in patients with glioblastomas.

13 Jul 2020

McLean Hospital study compares the costs and benefits of esketamine

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use.

13 Jul 2020

Research shows cardiovascular benefits of meditating

Meditation was linked to lower cardiovascular risk in a data analysis by Veterans Affairs researchers and colleagues.

13 Jul 2020

Baylor Scott & White Research Institute receives NIH award for esophageal cancer study

The incidence of esophageal adenocarcinoma has increased 8-fold over the past 50 years. This is one of the deadliest cancers, with a five-year survival rate of only 20 percent. However, the survival rate more than doubles if the cancer is identified early.

13 Jul 2020

Long-studied protein can be used as biomarker for traumatic brain injury

Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.

13 Jul 2020

New radiotracer can directly measure synaptic changes following stroke

A new radiotracer, 18F-SynVesT-2, can directly assess synaptic density changes in the brain, providing an objective and quantitative measure of disease progression after stroke.

13 Jul 2020

New collaboration will provide access to comprehensive stroke certification services in the Middle East

United Arab Emirates and Kingdom of Saudi Arabia institutions will have access to a single, comprehensive set of stroke certification services through a new collaboration between the Middle East and North Africa Stroke Organization and the American Stoke Association.

13 Jul 2020

Apathy not depression offers an important early warning sign of dementia

Apathy offers an important early warning sign of dementia in individuals with cerebrovascular disease, but depression does not, new research led by the University of Cambridge suggests.

13 Jul 2020

Delirium linked to long-term cognitive decline

A new meta-analysis of 24 observational studies from researchers at Columbia University Vagelos College of Physicians and Surgeons found that delirium may cause significant long-term cognitive decline.

13 Jul 2020

High-resolution TB-PET/CT scanner reveals complete picture of systemic inflammatory arthritis

For the first time, physicians can examine the systemic burden of inflammatory arthritis simultaneously across all joints and organ systems, using the high-sensitivity, high-resolution uEXPLORER total-body positron emission tomography/computed tomography (TB-PET/CT) scanner.

13 Jul 2020

Stress hormone is a crucial component of diabetes management, shows study

A new study by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine documents a clear link between the stress hormone cortisol and higher blood sugar levels in people with type 2 diabetes.

13 Jul 2020

Researchers analyze the effects of beta-blockers on men and women with hypertension

Women taking beta-blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospitals with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal.

13 Jul 2020

New opioid medication may slow the progression of osteoarthritis

A novel preclinical study by Keck Medicine of USC researchers, published in Arthritis & Rheumatology, reveals that a potential new opioid medication may have the ability to slow the progression of osteoarthritis while being less addictive than commonly prescribed opioid drugs.

13 Jul 2020